NCT07332351 clinical landscape for Muscle Invasive Bladder Urothelial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and developmen…

NCT07344051 clinical landscape for Moderate Atopic Dermatitis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07340853 clinical landscape for Recurrent Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07342517 clinical landscape for Urothelial Carcinoma of the Urinary Bladder: endpoints, sponsor, phase, geography, readouts, asset context and development…

NCT07342114 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07347418 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…

NCT07346053 clinical landscape for Bladder Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07352566 clinical landscape for Psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07355335 clinical landscape for Acute myeloid leukaemia with 11q23 abnormality: endpoints, sponsor, phase, geography, readouts, asset context and developm…

NCT07355075 clinical landscape for Eczema: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

NCT07356154 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.

ISRCTN63487177 clinical landscape for Pruritus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.